PDSB · PDS Biotechnology Corp · Executive Compensation
$0.75
+0.04 (+6.00%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$44.61M
Shares
55.97M
Volume · Oct 2
3.66M
Avg daily vol (3M)
21.61M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James Banaag | Class A director | Appointed | 2026-09-14 |
| Dr. Patrick Soon-Shiong | Class C director | Appointed | 2026-09-14 |
| Stephan Toutain | Chief Operating Officer | Terminated | 2026-08-25 |
| Frank Bedu-Addo | interim Principal Financial Officer | Appointed | 2026-08-19 |
| Janetta Trochimiuk | interim Principal Accounting Officer | Appointed | 2026-08-19 |
| Lars Boesgaard | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Resigned | 2026-08-19 |
| Gregory Freitag, J.D., C.P.A. | Class A director | Appointed | 2025-06-11 |
| Stephen Glover | Class A director | Appointed | 2025-06-11 |
| Sir Richard Sykes | member of the Board of Directors | Retired | 2025-04-24 |
| Stephan F. Toutain | Chief Operations Officer | Appointed | 2024-05-02 |
| Kirk V. Shepard, M.D. | Chief Medical Officer | Appointed | 2024-01-22 |
| Lauren V. Wood, M.D. | Chief Medical Officer | Retired | 2024-01-22 |
| Lars Boesgaard | Chief Financial Officer | Appointed | 2023-11-28 |
| Matthew Hill | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Resigned | 2023-11-28 |
| Ilian Iliev | Class B director | Appointed | 2023-07-17 |
| Kamil Ali-Jackson | Class B director | Appointed | 2023-07-17 |